KalVista Pharmaceuticals (KALV) Current Assets (2016 - 2024)
Historic Current Assets for KalVista Pharmaceuticals (KALV) over the last 10 years, with Q4 2024 value amounting to $286.0 million.
- KalVista Pharmaceuticals' Current Assets changed N/A to $286.0 million in Q4 2024 from the same period last year, while for Dec 2024 it was $286.0 million, marking a year-over-year change of. This contributed to the annual value of $225.7 million for FY2024, which is N/A changed from last year.
- Latest data reveals that KalVista Pharmaceuticals reported Current Assets of $286.0 million as of Q4 2024.
- KalVista Pharmaceuticals' Current Assets' 5-year high stood at $286.0 million during Q4 2024, with a 5-year trough of $62.5 million in Q1 2021.
- In the last 4 years, KalVista Pharmaceuticals' Current Assets had a median value of $116.4 million in 2023 and averaged $136.7 million.
- In the last 5 years, KalVista Pharmaceuticals' Current Assets tumbled by 3686.78% in 2021 and then surged by 2789.07% in 2024.
- KalVista Pharmaceuticals' Current Assets (Quarter) stood at $72.1 million in 2020, then dropped by 13.28% to $62.5 million in 2021, then surged by 105.76% to $128.6 million in 2023, then soared by 122.37% to $286.0 million in 2024.
- Its last three reported values are $286.0 million in Q4 2024, $152.3 million for Q4 2024, and $191.6 million during Q3 2024.